Mark L. Fuerst

Three new studies show exercise can improve cognitive function, psychotropics for PTSD may raise dementia risk, and 3 biomarkers can help predict cognitive decline in elderly persons.

The latest news in geriatric psychiatry covers olfactory deficits in cognitively impaired patients, a smartphone app for older adults with serious mental illness, and adjunctive ketamine for late-life depression.

Three recent studies on dementia show antioxidants lack preventive effects, autoimmune disease hospitalization is a risk factor, and cognitive stimulation has modest benefits.

Insights from 3 recent studies on the benefits of mental stimulation for mild cognitive impairment, effect of brain stimulation on memory, and risk of dementia in men with sleep apnea.

Highlights of 3 recent studies that focus on psychiatric disorders in older adults.

Three new studies offer insights into psychiatric disorders in the elderly.

Recent studies examine placebo responses to antidepressants, the effect of SSRIs on sleep in the elderly, and the best time of day for psychotherapy sessions.

Three new studies help predict which patients with depression may not respond to pharmacotherapy and which women may become depressed during menopause.

Three new studies in children with ADHD reveal an association with seizures, the benefits of after-school exercise, and brain changes linked to treatment.

Benefits of drug therapy include fewer STDs, injuries, and substance use disorders

Three recent studies assess the benefits of various therapies for MDD.

Three new studies focus on innovative therapies for ADHD.

Three new studies focus on innovative strategies to manage depression.

ADHD can occur in adulthood and may be a syndrome distinct from childhood-onset ADHD, according to a new study.

Three new studies focus on risk factors for the development of depressive disorders.

Do you know the 7 criteria that can help identify those at risk for unhealthy online gaming?

The studies discussed in this slideshow assess the benefits of non-traditional therapies for depressive disorders.

The guidelines and research discussed in this slideshow assess the benefits of various therapies for depressive disorders.

Three new studies show the effects of depression-and its treatment-on the brain.

How do the 3 FDA-approved dopamine receptor partial agonists for the treatment of MDD and other psychiatric disorders stack up against each other?